Association of renal papillary necrosis and ankylosing spondylitis
Open Access
- 30 April 1977
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 20 (4) , 917-921
- https://doi.org/10.1002/art.1780200403
Abstract
Three patients with ankylosing spondylitis developed renal papillary necrosis. All had received prosta‐glandin synthetase inhibitors including phenylbutazone, indomethacin, or ibuprofen. One patient had sickle trait. These drugs are not commonly associated with papillary necrosis in man, but may adversely effect renal medullary blood flow. An underlying renal vascular abnormality related to ankylosing spondylitis is also considered. Patients with ankylosing spondylitis who are taking prostaglandin synthetase inhibitors should be routinely screened for hematuria.This publication has 21 references indexed in Scilit:
- Prostaglandins and renal function II. The effect of prostaglandin inhibition on autoregulation of blood flow in the intact kidney of the dogProstaglandins, 1975
- Effect of A Renal Prostaglandin on Distribution of Blood Flow in the Isolated Canine KidneyCirculation Research, 1974
- Renal and gastric lesions after phenylbutazone and indomethacin in the ratPathology, 1974
- Medullary Ischaemia in Experimental Analgesic Nephropathy—The Pathogenesis of Renal Papillary Necrosis*Australian and New Zealand Journal of Medicine, 1973
- RENAL DISORDERS IN RHEUMATOID ARTHRITISRheumatology, 1971
- RENAL BIOPSIES FROM PATIENTS WITH A HIGH ANALGESIC INTAKEActa Pathologica Microbiologica Scandinavica, 1968
- Necrosis of the Renal Papillae in Rheumatoid ArthritisActa Medica Scandinavica, 1961
- TREATMENT OF UNUSUAL CASE OF ANURIAThe Lancet, 1960
- Hyaline arteriolosclerosis in the kidneyThe Journal of Pathology and Bacteriology, 1955
- TREATMENT OF RHEUMATOID ARTHRITIS WITH PHENYLBUTAZONEThe Lancet, 1953